Evidence Gaps

What do systematic reviews say?

1 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 2 · 100%

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs conventional western medicine (CWM) plus placebo

Recurrence angina pectoris with 1 month · patients with restenosis after percutaneous coronary intervention in coronary heart disease

Xiongshao capsule (XSC) plus conventional western medicine (CWM) leads to lower recurrence angina pectoris with 3 months' compared with conventional western medicine (CWM) plus placebo (high certainty).

2 findings from 1 review

Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
RR 0.37 [0.19, 0.71]
1 study · 314 participants
High
Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
RR 0.26 [0.18, 0.38]
2 studies · 432 participants
High